Campbell Soup (CPB)
$47.36 0.99 (2.05%)
19:17 EDT CPB Stock Quote Delayed 30 Minutes
Previous Close $47.36
Market Cap 14.24B
PE Ratio 29.79
Volume (Avg. Vol.) 2.60M
Day's Range 46.98 - 48.45
52-Week Range 35.27 - 57.54
Dividend & Yield 1.40 (2.96%)
CPB Stock Predictions, Articles, and Campbell Soup News
- From InvestorPlace
- From the Web
Although consumer stocks are out of favor, there are still some bargains in the sector to consider. Here are three that stand out.
Best Buy, MercadoLibre, Campbell Soup and EOG Resources all reported earnings, and are thus our top stock trades for Thursday.
The Campbell Soup earnings report for the company's fiscal second quarter of the year has CPB stock on the rise Wednesday.
Short-term headwinds have been bearing down on these large-cap stocks, making them potential stocks to sell soon.
Take advantage of the market uncertainty, political bickering and economic unrest with these smart stocks to invest in.
Consumer stocks are no longer the safe havens they once were, and young investors, in particular, should avoid them.
The stock charts of CPB, HD and JNPR merit some extra attention from traders as today's action gets going. Here's what to watch.
GE stock is just one of the many turnaround stocks in the market. These 16 equities all could be stocks to buy - if execution improves.
Campbell Soup stock was down on Thursday following the release of its earnings report for its fiscal fourth quarter of 2018.
Campbell's has diversified into snack foods under former CEO Denise Morrison, but can investors find value in CPB stock if it unwinds that.
A recent rumor claims that Kraft Heinz (KHC) is showing an interest in acquiring Campbell Soup Company (CPB), but only if it can get a deal on the company.
Campbell Soup (CPB) is alerting customers to a Pepperidge Farm Goldfish recall due to a risk of salmonella from whey powder.
According to S&P Global Ratings, US companies have $4.2 trillion in net debt. Here are seven S&P 500 companies whose debt looks worrisome.
One of my favorite market signals is flashing red, portending major weakness later this year and next. Even as the S&P 500 has struggled to remain positive....
CPB stock jumped almost 10% Monday on reports that Kraft Heinz may be an interested buyer. However, Campbell Soup needs more than that to justify an investment.
From Analyst Ratings
In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Buy rating to Alpine Immune Sciences (ALPN – Research Report), with a price target of $12.00. The company’s shares closed last Thursday at $3.05. According to TipRanks.com, Breidenbach is a 5-star analyst with an average return of 8.8% and a 45.9% success rate. Breidenbach
From Simply Wall St
Anyone researching Alpine Immune Sciences, Inc. (NASDAQ:ALPN) might want to consider the historical volatility of the share price. Volatility is considered to be a measure of risk in modern finance<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alpn/alpine-immune-sciences/news/what-you-must-know-about-alpine-immune-sciences-inc-s-nasdaqalpn-beta-value/">Read More...</a></div>
The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions
Navellier RatingsPowered by Portfolio Grader